[1] MEDDINGS L, MYERS R P, HUBBARD J, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends[J]. Am J Gastroenterol, 2010, 105(1):117-124. doi:  10.1038/ajg.2009.614
[2] YIN D, JI C, ZHANG S, et al. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: a 12-year retrospective study[J]. Liver Int, 2021, 41(4):810-818. doi:  10.1111/liv.14760
[3] 中华医学会急诊医学分会. 细菌性肝脓肿诊治急诊专家共识[J]. 中华急诊医学杂志, 2022, 31(3):273-280. doi:  10.3760/cma.j.issn.1671-0282.2022.03.003
[4] 中华医学会外科学分会, 中国研究型医院学会感染性疾病循证与转化专业委员会, 中华外科杂志编辑部. 外科常见腹腔感染多学科诊治专家共识[J]. 中华外科杂志, 2021, 59(3):161-178. doi:  10.3760/cma.j.cn112139-20201223-00874
[5] 戴维·吉尔伯特, 亨利·钱伯斯, 迈克尔·萨格, 等. 桑福德抗微生物治疗指南[M]. 第50版. 北京: 中国协和医科大学出版社, 2021: 39.
[6] 中国医药教育协会感染疾病专业委员会. 感染相关生物标志物临床意义解读专家共识[J]. 中华结核和呼吸杂志, 2017, 40(4):243-257. doi:  10.3760/cma.j.issn.1001-0939.2017.04.002
[7] 降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志, 2012, 21(9):944-951. doi:  10.3760/cma.j.issn.1671-0282.2012.09.005
[8] 中国医药教育协会感染疾病专业委员会. 降钙素原指导抗菌药物临床合理应用专家共识[J]. 中华医学杂志, 2020, 100(36):2813-2821. doi:  10.3760/cma.j.cn112137-20200714-02112
[9] CHEN Y C, LIN C H, CHANG S N, et al. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000—2011[J]. J Microbiol Immunol Infect, 2016, 49(5):646-653. doi:  10.1016/j.jmii.2014.08.028
[10] 毛玉巧, 付喜花. 71例肝脓肿临床及病原学特点分析[J]. 广州医药, 2021, 52(4):55-59. doi:  10.3969/j.issn.1000-8535.2021.04.012
[11] LIU L, CHEN W J, LU X Y, et al. Pyogenic liver abscess: a retrospective study of 105 cases in an emergency department from East China[J]. J Emerg Med, 2017, 52(4):409-416. doi:  10.1016/j.jemermed.2016.09.026
[12] SONG H W, WANG X B, LIAN Y B, et al. Analysis of the clinical characteristics of 202 patients with liver abscess associated with diabetes mellitus and biliary tract disease[J]. J Int Med Res, 2020, 48(8): 300060520949404.
[13] 冯静. 回顾性分析糖尿病细菌性肝脓肿患者合并肝胆胰疾病的临床特点及危险因素[J]. 肝胆外科杂志, 2020, 28(6):423-426.
[14] 吴华, 李东冬, 王京, 等. 肺炎克雷伯菌肝脓肿的临床及微生物特征分析[J]. 中华医学杂志, 2015, 95(40):3259-3263. doi:  10.3760/cma.j.issn.0376-2491.2015.40.005
[15] SERRAINO C, ELIA C, BRACCO C, et al. Characteristics and management of pyogenic liver abscess: a European experience[J]. Medicine, 2018, 97(19):e0628. doi:  10.1097/MD.0000000000010628
[16] QIAN Y, WONG C C, LAI S, et al. A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015[J]. Sci Rep, 2016, 6(1):38587. doi:  10.1038/srep38587
[17] YOO J J, LEE T K, KYOUNG D S, et al. A population-based study of pyogenic liver abscess in Korea: incidence, mortality and temporal trends during 2007—2017[J]. Liver Int, 2021, 41(11):2747-2758. doi:  10.1111/liv.15034
[18] 周宜庆, 曾敏, 周洁, 等. 导致肝脓肿的肠杆菌科细菌的耐药性分析[J]. 临床肝胆病杂志, 2018, 34(8):1750-1753. doi:  10.3969/j.issn.1001-5256.2018.08.031
[19] ARCHAMBAULT M, RUBIN J E. Antimicrobial resistance in Clostridium and Brachyspira spp. and other anaerobes[J]. Microbiol Spectr, 2020, 8(1).
[20] 薛晓燕, 周曙俊. 厌氧菌感染的临床处置误区与抗厌氧菌药物的合理使用[J]. 中国医院药学杂志, 2016, 36(18):1605-1608.
[21] AHMED M, ALAM J, HUSSAIN S, et al. Prospective randomized comparative study of percutaneous catheter drainage and percutaneous needle aspiration in the treatment of liver abscess[J]. ANZ J Surg, 2021, 91(3):E86-E90.
[22] 卢元元, 潘莉丽, 张向芙, 等. 临床药师参与抗菌药物所致粒细胞减少患者的临床用药治疗与药学监护[J]. 抗感染药学, 2020, 17(9):1367-1371.